ECOR
electroCore, Inc.
There isn't enough reported data to score ECOR yet.
ECOR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
ECOR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ECOR PE Valuation
ECOR has no meaningful PE right now: it lost money over the past year.
ECOR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect ECOR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ECOR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$1.68 | +$0.01 |
| Q2 2025 | -$1.59 | +$0.47 |
| Q1 2025 | -$1.53 | +$1.18 |
| Q4 2024 | -$1.59 | +$1.83 |
| Q3 2022 | -$4.50 | +$0.45 |
| Q2 2022 | -$4.20 | +$1.35 |
| Q1 2022 | -$3.90 | +$2.70 |
| Q4 2021 | -$4.35 | +$4.65 |
ECOR is still losing money, but far less than before: $1.68 per share over the past year, against $23.10 at its worst in late 2019.
ECOR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.7M | +12% |
| Q2 2026 | $9.5M | +28% |
| Q1 2026 | $9.6M | +43% |
| Q4 2025 | $9.2M | +31% |
| Q3 2025 | $8.7M | +33% |
| Q2 2025 | $7.4M | +20% |
| Q1 2025 | $6.7M | +23% |
| Q4 2024 | $7M | +36% |
ECOR's revenue has grown year over year every quarter since late 2020: $10M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +17 points |
| Q2 2026 | -29% | +18 points |
| Q1 2026 | -55% | +1.4 points |
| Q4 2025 | -32% | +12 points |
| Q3 2025 | -33% | +7.3 points |
| Q2 2025 | -48% | -5.3 points |
| Q1 2025 | -57% | +14 points |
| Q4 2024 | -44% | +33 points |
ECOR's operating margin was −16% last quarter, up 17 points from the same quarter a year ago, near the top of its range since 2019.
ECOR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.8M | -$1.2M |
| Q2 2026 | -$3.5M | -$2.9M |
| Q1 2026 | -$3M | +$1.4M |
| Q1 2025 | -$4.4M | -$1.8M |
| Q1 2024 | -$2.6M | +$3.3M |
| Q4 2023 | -$3.2M | +$850K |
| Q3 2023 | -$2.4M | +$2.2M |
| Q1 2023 | -$5.9M | -$1.1M |
ECOR has burned cash in almost every quarter: −$11M over the past year, against −$9M the year before.
ECOR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +33% | +2.5M shares |
| 1 year | +50% | +3.3M shares |
| 3 years | +283% | +7.4M shares |
ECOR has 10M diluted shares, up 50% from a year ago.
ECOR Net Leverage
ECOR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ECOR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 17.3 | Oversold |
ECOR's weekly RSI is 39 (neutral) and its Stochastic is 17 (oversold).
ECOR PE vs Healthcare Sector
ECOR has no meaningful PE right now: it lost money over the past year.
ECOR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.23 | 36% below |
| 20 week MA | $8.41 | 37% below |
| 50 week MA | $7.30 | 28% below |
| 100 week MA | $7.79 | 32% below |
| 200 week MA | $7.05 | 25% below |
ECOR is in a downtrend: it's below all five of its weekly moving averages, and 25% below its 200-week average.
ECOR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.7 | $24.2 | +23% |
| 2021 | $24.2 | $10.4 | -57% |
| 2022 | $10.4 | $4.61 | -56% |
| 2023 | $4.61 | $5.95 | +29% |
| 2024 | $5.95 | $16.5 | +177% |
| 2025 | $16.5 | $4.95 | -70% |
| 2026 YTD | $4.95 | $5.29 | +6.9% |
ECOR's yearly returns have swung widely, from +177% in 2024 to −70% in 2025. It's up 6.9% so far in 2026.